SURVEILLANCE IN PUBLIC HEALTH Health Surveillance of Products [VS2] Health Surveillance of Products Drug and Narcotic Control [VS2.002] Drug and Narcotic Control Pharmaceutical Preparations [VS2.002.001] Pharmaceutical Preparations Homeopathic Remedy [VS2.002.001.001] Homeopathic Remedy Reference Drugs [VS2.002.001.002] Reference Drugs Drugs, Generic [VS2.002.001.003] Drugs, Generic Similar Drugs [VS2.002.001.004] Similar Drugs Phytotherapeutic Drugs [VS2.002.001.005] Phytotherapeutic Drugs Nonprescription Drugs [VS2.002.001.006] Nonprescription Drugs Prescription Drugs [VS2.002.001.007] Prescription Drugs Drugs, Chinese Herbal [VS2.002.001.008] Drugs, Chinese Herbal Flower Essences [VS2.002.001.009] Flower Essences Biological Products [VS2.002.001.010] Biological Products Drugs on Basis of Vitamins and Minerals [VS2.002.001.011] Drugs on Basis of Vitamins and Minerals Anti-Bacterial Agents [VS2.002.001.012] Anti-Bacterial Agents Drugs, Essential [VS2.002.001.013] Drugs, Essential Drugs from the Specialized Component of Pharmaceutical Care [VS2.002.001.014] Drugs from the Specialized Component of Pharmaceutical Care Drugs of Special Control [VS2.002.001.015] Drugs of Special Control Illicit Drugs [VS2.002.001.016] Illicit Drugs Hepatoprotector Drugs [VS2.002.001.017] Hepatoprotector Drugs Drugs of Continuous Use [VS2.002.001.018] Drugs of Continuous Use Drugs for Primary Health Care [VS2.002.001.019] Drugs for Primary Health Care Bioequivalent Drugs [VS2.002.001.020] Bioequivalent Drugs Fractionated Drugs [VS2.002.001.021] Fractionated Drugs Narcotics [VS2.002.001.022] Narcotics Psychotropic Drugs [VS2.002.001.023] Psychotropic Drugs Pharmaceutical Raw Material [VS2.002.001.024] Pharmaceutical Raw Material Potentially Inappropriate Medication List [VS2.002.001.587] Potentially Inappropriate Medication List

Bioequivalent Drugs - Preferred

Concept UI	FD00061644
Scope note	Pharmaceutical equivalents which, when administered in the same molar dose under the same experimental conditions, show no statistically significant differences regarding bioavailability.
Preferred term	Bioequivalent Drugs
Entry term(s)	Pharmaceutical Equivalents